Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
22.30
-0.04 (-0.18%)
At close: Sep 11, 2026, 4:00 PM EDT
23.11
+0.81 (3.63%)
After-hours: Sep 11, 2026, 7:30 PM EDT
Vor Biopharma Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Vor Biopharma stock has a consensus rating of "Strong Buy" and an average price target of $39. The average 1-year stock price forecast is 74.89% higher than the current stock price, while the lowest is $27 (+21.08%) and the highest is $50 (+124.22%).
Price Target: $39 (+74.89%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Vor Biopharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $50 | Buy | Maintains | $50 | +124.22% | Sep 10, 2026 |
| Jefferies | Jefferies | Buy Maintains $48 | Buy | Maintains | $48 | +115.25% | Sep 9, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $30 | Buy | Maintains | $30 | +34.53% | Aug 31, 2026 |
| Wedbush | Wedbush | Hold Maintains $18 → $27 | Hold | Maintains | $18 → $27 | +21.08% | Aug 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $31 | Buy | Reiterates | $31 | +39.01% | Aug 12, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-6.53
from -70.50
EPS Next Year
-3.81
from -6.53
EPS and Forward PE are based on non-GAAP adjusted numbers.